Carla Martín Pérez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carla Martín Pérez has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Anna Ruiz-Comellas
Faculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Spain
3 shared publications - Carlota Dobaño
ISGlobal, Barcelona, Spain
3 shared publications - Gemma Moncunill
ISGlobal, Barcelona, Spain
3 shared publications - Luis Izquierdo
ISGlobal, Barcelona, Spain
3 shared publications - Luis Manuel Molinos-Albert
ISGlobal, Barcelona, Spain
3 shared publications Marta Vidal
ISGlobal, Barcelona, Spain
3 shared publications
Latest Publications
- Open Access
- 24 June 2026
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1)
First exposure to SARS-CoV-2 shapes IgG subclass switching after mRNA vaccination
Background mRNA vaccines against SARS-CoV-2 have proven highly effective in reducing severe disease and death, but repeated administration induces an unusual shift in IgG subclasses. In particular, increases in IgG2 and IgG4 raise questions about their regulation, persistence, and implications for protective immunity. Methods To investigate the longitudinal dynamics and factors influencing IgG subclasses and their impact on protective immunity, we analyzed the levels of IgG1–4 subclasses, C1q, and FcγR-binding IgG against antigens from multiple SARS-CoV-2 variants in a well-characterized cohort of healthcare workers in Spain. Results Our findings indicate that subclass responses are shaped by exposure history, with infection before vaccination limiting the extent of IgG2 and IgG4 class switching relative to infection after vaccination. IgG4 exhibits broader reactivity to Omicron variants than IgG1, and both IgG2 and IgG4 show slower decay of circulating antibody levels than IgG1. IgG4 levels correlate with FcγR- and C1q-binding antibodies only in participants with lower IgG1, suggesting competition between subclasses. During Omicron predominance, elevated IgG2 and IgG4 are linked to increased risk of breakthrough infection in vaccinees, whereas levels of IgG1 and FcγR- and C1q-binding antibodies are associated with protection. Conclusions Our findings highlight marked differences in IgG subclass profiles according to first exposure history and suggest that IgG subclass distribution and persistence may influence antibody-mediated immunity following mRNA vaccination. Further studies are warranted to clarify the mechanistic and clinical implications of IgG subclass shift for long-term protection.
- 24 June 2026
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1)
Open AccessFirst exposure to SARS-CoV-2 shapes IgG subclass switching after mRNA vaccination
Background mRNA vaccines against SARS-CoV-2 have proven highly effective in reducing severe disease and death, but repeated administration induces an unusual shift in IgG subclasses. In particular, increases in IgG2 and IgG4 raise questions about their regulation, persistence, and implications for protective immunity. Methods To investigate the longitudinal dynamics and factors influencing IgG subclasses and their impact on protective immunity, we analyzed the levels of IgG1–4 subclasses, C1q, and FcγR-binding IgG against antigens from multiple SARS-CoV-2 variants in a well-characterized cohort of healthcare workers in Spain. Results Our findings indicate that subclass responses are shaped by exposure history, with infection before vaccination limiting the extent of IgG2 and IgG4 class switching relative to infection after vaccination. IgG4 exhibits broader reactivity to Omicron variants than IgG1, and both IgG2 and IgG4 show slower decay of circulating antibody levels than IgG1. IgG4 levels correlate with FcγR- and C1q-binding antibodies only in participants with lower IgG1, suggesting competition between subclasses. During Omicron predominance, elevated IgG2 and IgG4 are linked to increased risk of breakthrough infection in vaccinees, whereas levels of IgG1 and FcγR- and C1q-binding antibodies are associated with protection. Conclusions Our findings highlight marked differences in IgG subclass profiles according to first exposure history and suggest that IgG subclass distribution and persistence may influence antibody-mediated immunity following mRNA vaccination. Further studies are warranted to clarify the mechanistic and clinical implications of IgG subclass shift for long-term protection.
- Open Access
- 13 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Primary SARS-CoV-2 exposure by vaccination or infection shapes immune responses to omicron variants among a Spanish cohort
The comparison between vaccine-induced and infection-acquired adaptive immunity, and their co-occurrence —referred to as “hybrid immunity”— is of great interest and remains an area with significant knowledge gaps. Given that most of the population already has hybrid immunity to COVID-19, a key question is whether the order of infection-acquired and vaccine-induced immunity affects the immune response. Here, we analyze the humoral and T-cell responses in a Spanish cohort with longitudinal blood sampling spanning 2020-2023. We observe higher anti-RBD antibody levels against Omicron in individuals initially exposed to SARS-CoV-2 antigens via vaccination compared to those first exposed through natural infection. This difference diminishes with an increasing number of exposures. The dynamics of antibody levels over time correlate with clinical protection: those first-infected have higher protection early on, whereas those first-vaccinated show greater protection later, especially with the arrival of the Omicron variant. This phenomenon may reflect immune imprinting. In contrast to the humoral response, the T-cell response is higher in individuals first exposed through infection, although T-cell findings may be underpowered because of limited sample size. Our study provides valuable insights into the impact of initial antigen exposure on humoral and cellular responses to SARS-CoV-2.
- 13 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessPrimary SARS-CoV-2 exposure by vaccination or infection shapes immune responses to omicron variants among a Spanish cohort
The comparison between vaccine-induced and infection-acquired adaptive immunity, and their co-occurrence —referred to as “hybrid immunity”— is of great interest and remains an area with significant knowledge gaps. Given that most of the population already has hybrid immunity to COVID-19, a key question is whether the order of infection-acquired and vaccine-induced immunity affects the immune response. Here, we analyze the humoral and T-cell responses in a Spanish cohort with longitudinal blood sampling spanning 2020-2023. We observe higher anti-RBD antibody levels against Omicron in individuals initially exposed to SARS-CoV-2 antigens via vaccination compared to those first exposed through natural infection. This difference diminishes with an increasing number of exposures. The dynamics of antibody levels over time correlate with clinical protection: those first-infected have higher protection early on, whereas those first-vaccinated show greater protection later, especially with the arrival of the Omicron variant. This phenomenon may reflect immune imprinting. In contrast to the humoral response, the T-cell response is higher in individuals first exposed through infection, although T-cell findings may be underpowered because of limited sample size. Our study provides valuable insights into the impact of initial antigen exposure on humoral and cellular responses to SARS-CoV-2.
- Open Access
- 20 June 2025
- Published by Springer Nature in Communications Medicine
- Vol. 5 (1) , 1-13
Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection
Background The ongoing evolution of SARS-CoV-2, particularly through the emergence of new variants, continues to challenge our understanding of immune protection. While antibody levels correlate with protection against earlier variants such as Alpha and Delta, their relationship with Omicron sub-variants remains unclear. Methods To investigate the role of antibody levels and neutralizing activity in preventing breakthrough infections, we analyzed longitudinal SARS-CoV-2 humoral responses and neutralizing activity against the ancestral virus and major emerging variants in a well-characterized cohort of healthcare workers in Spain (N = 405). Results We find that antibody levels and neutralization titers are key indicators of protection against SARS-CoV-2, including the more evasive BQ.1 and XBB Omicron variants. Higher IgG and IgA levels are associated with protection over three 6-month follow-up periods sequentially dominated by BA.1, BA.2, BA.5, BQ.1, and XBB Omicron sub-variants, although the strength of the association between antibody levels and protection declines over time. Conclusions Our findings demonstrate that binding antibody levels and neutralizing responses are valid correlates of protection against more evasive BQ.1 and XBB Omicron variants, although the strength of this association diminishes over time. Additionally, our results underscore the importance of continuous monitoring and updating vaccination strategies to maintain effective protection against emerging SARS-CoV-2 variants.
- 20 June 2025
- Published by Springer Nature in Communications Medicine
- Vol. 5 (1) , 1-13
Open AccessDeterminants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection
Background The ongoing evolution of SARS-CoV-2, particularly through the emergence of new variants, continues to challenge our understanding of immune protection. While antibody levels correlate with protection against earlier variants such as Alpha and Delta, their relationship with Omicron sub-variants remains unclear. Methods To investigate the role of antibody levels and neutralizing activity in preventing breakthrough infections, we analyzed longitudinal SARS-CoV-2 humoral responses and neutralizing activity against the ancestral virus and major emerging variants in a well-characterized cohort of healthcare workers in Spain (N = 405). Results We find that antibody levels and neutralization titers are key indicators of protection against SARS-CoV-2, including the more evasive BQ.1 and XBB Omicron variants. Higher IgG and IgA levels are associated with protection over three 6-month follow-up periods sequentially dominated by BA.1, BA.2, BA.5, BQ.1, and XBB Omicron sub-variants, although the strength of the association between antibody levels and protection declines over time. Conclusions Our findings demonstrate that binding antibody levels and neutralizing responses are valid correlates of protection against more evasive BQ.1 and XBB Omicron variants, although the strength of this association diminishes over time. Additionally, our results underscore the importance of continuous monitoring and updating vaccination strategies to maintain effective protection against emerging SARS-CoV-2 variants.
- Open Access
- 23 October 2024
- Published by Elsevier in Extracellular Vesicle
- Vol. 4
An extracellular vesicle delivery platform based on the PTTG1IP protein
- 23 October 2024
- Published by Elsevier in Extracellular Vesicle
- Vol. 4
Open AccessAn extracellular vesicle delivery platform based on the PTTG1IP protein